Personalization of Opioid Prescription Following Orthognathic Surgery
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate pain management and satisfaction following orthognathic
surgery, which is a type of surgery that corrects jaw and facial bone issues. This type of
surgery can result in significant post-operative pain for participants, and the goal of this
study is to find a way to manage this pain in a more effective and safe manner.
The study will focus on the use of opioid pain medication and will compare two groups: one
group will receive a standardized prescription plan. In contrast, the other group will
receive a personalized prescription with a plan to taper the opioid medication. In the end,
any unused opioid will be compared at the end of the 7-day post-discharge period between the
two groups. This is important because excessive opioid prescription can either be diverted to
the community or can be misused leading to opioid use disorders.
Data will be collected from pre-surgery appointments, during the surgery and hospital stay,
and follow-up appointments. The data collected will include participants' demographics,
medical history, type of surgery, and information about the pain medication used.
The study hypothesizes that the personalized prescription plan will result in less unused
medication and higher satisfaction with pain management compared to the standardized
prescription plan. The study will also stratify the participants into single-jaw surgery and
double-jaw surgery groups to evaluate if any differences in the outcomes are observed. This
study will help to provide guidance for future pain management practices for participants
undergoing orthognathic surgery. Furthermore, this study will also benefit society by
providing insights into addressing the opioid crisis that is currently affecting many
communities across North America.